A new Brainwave test for ADHD diagnosis has gained FDA approval
|
A new Brainwave test for ADHD diagnosis has gained FDA approval |
Attention Deficient Hyperactivity Disorder (ADHD) affects
11% of children ages 4-17, and the numbers diagnosed continue to rise. ADHD
continues to be one of the most common childhood mental health conditions.
Children with ADHD may be inattentive, hyperactive, and can be inappropriately
impulsive in their actions. Children with untreated ADHD can experience
substantial problems with their personal relationships, school performance, and
have been reported to have more substance use problems in adulthood. Over a
third of children with autism may also have ADHD according to the lastest
research.
Traditionally ADHD has been diagnosed based on a
psychological and medical interview, information from school teachers, and a
direct observation of a child’s behavior. Until recently the most objective
diagnostic tool for ADHD was the use of paper rating scales.